Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation

Lupus

Volumn 15, Issue 1, 2006, Pages 44-46

  Marmont, A M ^a   Gualandi, F ^a   Van Lint, M T ^a   Guastoni, C ^b   Bacigalupo, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale Civile   (Italy)

Author keywords

Autologous stem cell transplantation; Lupus nephritis; Nephrotic syndrome

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; THIOTEPA;

ADULT; ANAMNESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; EDEMA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REMISSION; STEM CELL MOBILIZATION; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD34; BIOPSY; FOLLOW-UP STUDIES; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; NEPHROTIC SYNDROME; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33144465720     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2241cr     Document Type: Article

References (14)

1. Marmont AM. Perspective. Immunoablation with stem cell rescue: a possible cure for systemic lupus erythematosus. Lupus 1993; 2: 19-156.
2. Tyndall A, Fassas A, Passweg J et al. Autologous haematopoietic stem cell transplant for autoimmune disease-feasability and transplant-related mortality. Bone Marrow Transplant 1999; 24: 729-734.
3. Marmont AM, van Lint MT, Gualandi F, Bacigalupo A. Autologous stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997; 6: 545-548.
4. Traynor AE, Barr WG, Rosa RM et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 2002; 46: 2917-2923.
5. Jayne D, Passweg, Marmont A et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13: 168-173.
6. Starkute L, Traynor A, Oyama Y et al. Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood 2005; 106: 2702-2711.
7. Gualandi F, Marmont AM, Mancardi GL et al. Stem cell transplantation for severe autoimmune diseases. A single-centre experience. Bone Marrow Transplant 2005; 35(suppl. 2): 231-232.
8. Raiola AM, van Lint MT, Lamparelli T et al. Reduced intensify thiotepa-cyclophosphamide conditioning for allogenic haematopoietic stem cell transplantation (HSCT) in patients upto 60 years of age. Br J Haematol 2000; 109: 716-772.
9. Gratwohl A, Passweg J, Bocelli-Tyndall C et al. Autologous hematopoieitc stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35: 869-879.
10. Burt RK, Fassas A, Snowden J et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28: 1-12.
11. Sun W, Popat U, Hutton G et al. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 2004; 127: 996-1008.
12. Muraro P, Douek DC, Packer A et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exper Med 2005; 201: 805-816.
13. Hinterberger W, Hinterberger-Fischer M, Marmont A. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753-759.
14. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435: 620-627